Last reviewed · How we verify
RCT of Zhi Byed 11 (ZB11) Versus Misoprostol in Tibet
Previous research has confirmed that hemorrhage is among the most commonly encountered pregnancy complications in the Tibet Autonomous Region (TAR). This trial will test the effectiveness of a traditional Tibetan drug (Zhi Byed 11) vs. misoprostol to prevent postpartum hemorrhage (PPH) among women delivering vaginally in three hospitals in Lhasa, TAR.
Details
| Lead sponsor | NICHD Global Network for Women's and Children's Health |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 848 |
| Start date | 2005-09 |
| Completion | 2007-03 |
Conditions
- Hemorrhage
Interventions
- Zhi Byed 11
Primary outcomes
- Postpartum hemorrhage
- Maternal death
Countries
China